US: 800.298.5699
Int'l: +1.240.747.3093
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
|
|
|
Biopharmaceuticals Market Research Reports
Find the information you need on biopharmaceuticals. Our collection of industry research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
|
Biosimilars > 22
|
|
|
|
Title
|
Published
|
Price
|
|
Biotechnology (Pharmaceuticals) Report
By: Plimsoll Publishing Ltd.
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
|
more...
|
11/1/2009
|
$1,500.00
|
|
Biopharmaceuticals Industry Report
By: Plimsoll Publishing Ltd.
The Global Biopharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial
|
more...
|
11/1/2009
|
$1,500.00
|
|
Freedonia Focus on Biologicals
By: Freedonia Focus
This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment,
|
more...
|
10/31/2009
|
$500.00
|
|
H4-13, Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
By: Decision Resources
Introduction:
The third quarter of 2009 saw a heated debate in the United States over healthcare reform, the publication of a
report on a European investigation of the pharmaceutical industry, the election of new governments
|
more...
|
10/28/2009
|
$2,250.00
|
|
Biosimilars: Beyond the First Product Wave
By: Espicom Healthcare Intelligence
With the prospect of high-profile, high-value biosimilar products on the horizon, the sector is poised to realise its full potential - but only if the US can establish a regulatory pathway. This report addresses key
|
more...
Search inside this report
|
10/15/2009
|
$2,460.00
|
|
The CMO Market Outlook: Emerging markets, key players and future trends
By: Business Insights
Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fix costs including large manufacturing facilities. Sponsors are turning to CMOs in search of time and cost savings and as a
|
more...
|
10/1/2009
|
$3,835.00
|
|
The Global Biopharmaceuticals Industry Report
By: Plimsoll Publishing Ltd.
The Global Biopharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial
|
more...
|
9/24/2009
|
$1,500.00
|
|
Biosimilars (2009 - 2014)
By: MarketsandMarkets
The impending expiry of several patented blockbuster biopharmaceuticals and the increasing demand from patients, insurers, and government agencies to reduce drug costs have created numerous opportunities in the global biosimilars market. The global biosimilars market
|
more...
Search inside this report
|
9/24/2009
|
$4,650.00
|
|
The Global Biotechnology (Pharmaceuticals) Report
By: Plimsoll Publishing Ltd.
The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation
|
more...
|
9/24/2009
|
$1,500.00
|
|
A Global Recession Drives New Business Strategies and Evolving Business Models in the Biopharma Industry
By: Decision Resources
The biotechnology and pharmaceutical sectors as we know them will soon cease to exist. Companies in these
sectors have come face-to-face with the harrowing ordeals of a global recession. Four stresses on the industry
are
|
more...
|
9/15/2009
|
$2,250.00
|
|
Biopharma Quarter: Key Trends and Events of the Second Quarter of 2009
By: Decision Resources
The first Phase 0 trial results, thefirst fruits of Japan’s biosimilar pathway, the first straightforward use of the social
marketing tool Twitter to advance a drug franchise, thefirst moves of the EU to regulate third-party
|
more...
|
9/10/2009
|
$2,250.00
|
|
Best Practices for Post-Marketing Surveillance of Adverse Events within the U.S.
By: Best Practices, LLC
STUDY OVERVIEW
Medical and scientific progress has been enormous in the past decades. However, this has also raised several safety issues leading to increased vigilance on bio-pharma companies by the U.S. Food and Drug Administration
|
more...
|
9/1/2009
|
$2,895.00
|
|
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
By: Kalorama Information
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and
|
more...
Search inside this report
|
9/1/2009
|
$2,995.00
|
|
Commercial Insight: Molecular Targeted Cancer Therapies Leading Companies will hold onto Competitive Advantage in High Growth Market
By: Datamonitor
Introduction
Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key
|
more...
|
8/18/2009
|
$15,200.00
|
|
Molecular Targeted Cancer Therapies Market Forecast
By: Datamonitor
Introduction
Molecular targeted cancer therapies are the biggest and fastest growing class of cancer drugs in terms of sales. As growth of revenues from cytotoxic therapies and antihormonal therapies has slowed and many key
|
more...
|
8/18/2009
|
$15,200.00
|
|
Pipeline Insight: Prostate Cancer Molecular Targeted Therapies will fulfill Unmet Needs in Castration-Resistant Disease
By: Datamonitor
Introduction
Incidence of prostate cancer in the seven major markets will be just over 422,000 in 2009, indicating high patient potential for drug developers to invest in. There are currently 136 agents in development
|
more...
|
8/14/2009
|
$11,400.00
|
|
The World Market for Biosimilars and the Potential for US Follow-on Biologics
By: Kalorama Information
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and
|
more...
Search inside this report
|
8/1/2009
|
$3,700.00
|
|
Biological products, except diagnostic: Industry Cluster Report
By: BizMiner
13 industry segments are analyzed over a 3-year time series in this industry market analysis; The report applies data from 696 firms, examing industry segment sales, small business vitality, failure and startup rates, sales
|
more...
|
7/15/2009
|
$440.00
|
|
2008/2009 Biotechnology Research Review
By: BCC Research
The global economic downturn that began in 2008 has slowed growth in nearly all technology sectors, including biotechnology markets. Nonetheless, the high value that biotechnology products can deliver, and the long-term growth potential of the
|
more...
Search inside this report
|
7/1/2009
|
$850.00
|
|
Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics
By: Best Practices, LLC
STUDY OVERVIEW
Forward-thinkers in the biopharmaceutical industry recognize employers as true payers of healthcare, ready to assume a more active role in healthcare decision making. As a result, many companies are seeking ways to
|
more...
|
7/1/2009
|
$3,395.00
|
|
Medical Affairs Resources, Structures and Trends
By: Best Practices, LLC
STUDY OVERVIEW
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions - including publications, KOL programs, grants, and medical education (CME) that have been impacted in recent years
|
more...
|
7/1/2009
|
$4,100.00
|
|
Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics
By: CurrentPartnering
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the worlds leading biopharma companies.
This
|
more...
Search inside this report
|
7/1/2009
|
$2,395.00
|
|
Autoimmune Disease Therapeutics
By: Global Industry Analysts
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Billion by the following therapeutic class - Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohn's Disease (Biologics only), and Others. The report provides separate comprehensive
|
more...
|
7/1/2009
|
$3,950.00
|
|
Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights
By: Best Practices, LLC
Today’s physicians are rapidly losing their influence over patients’ drug utilization decisions and unfortunately a large number of bio-pharmaceutical companies have failed to recognize that third-party payers, such as government and commercial organizations, now control
|
more...
|
7/1/2009
|
$4,600.00
|
|
Biosimilars and Biobetters: Positioning for a New Market
By: Biophoenix Limited
Patents on the earliest approved biologics, including many blockbusters with over $1 billion in annual sales, have started to expire. This has opened the market to biosimilar competition, initially in the EU, where a total
|
more...
Search inside this report
|
7/1/2009
|
$3,230.00
|
|
Title
|
Published
|
Price
|
|
|
(0 items)
